Low Pressure Gradients

Because the ATS 3f® Aortic Bioprosthesis preserves the sinuses while restoring physiologic flow and native valve stress distribution, surgeons are impressed by the low mean pressure gradients they have achieved with ATS 3f.

The ATS 3f Aortic Bioprosthesis is designed to achieve long-term durability.¹

• Preserves aortic sinuses
• Restores physiologic flow
• Restores native valve stress distribution
• Provides low pressure gradients

Long-Term Durability

*Toronto SPV is a registered trademark of St. Jude Medical, Inc or one of its affiliates.
**PERIMOUNT is a registered trademark of Edwards Lifesciences Corporation.

1. Data on file. ATS Medical, Inc.

INDICATIONS:
The ATS 3f® Aortic Bioprosthesis, Model 1000 is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves.

CONTRAINDICATIONS:
The ATS 3f® Aortic Bioprosthesis, Model 1000 should not be used in those patients who present with congenital bicuspid anatomy or other forms of abnormal aortic root geometry.

WARNINGS/PRECAUTIONS/SIDE EFFECTS:
Accelerated deterioration of the Model 1000 valve due to calcific degeneration may occur in children, adolescents, or young adults, or in patients with altered calcium metabolism such as patients on maintenance hemodialysis for chronic renal failure, patients with hyperparathyroidism, patients on high calcium diets, or patients requiring chronic calcium-containing drug therapy. The performance of the Model 1000 valve is, as is the case for all stentless bioprosthetic valves, dependent on accurate matching of the valve to the recipient patient’s aortic annular and sinotubular dimensions and may be adversely affected by high aortic root compliance. General complications potentially associated with the use of bioprosthetic heart valves include: leak (transvalvular, perivalvular), cardiac dysrhythmias, endocarditis, hemolysis, hemorrhage, non-structural dysfunction [NSD] (entrapment by pannus or suture, inappropriate sizing or positioning, or other), structural deterioration (intrinsic and extrinsic calcification, leaflet perforation or tear, leaflet thickening, or myxomatous degeneration), prosthesis stenosis, prosthesis regurgitation, valve thrombosis, thromboembolism.

CAUTION:
Federal law restricts this device to sale by or on the order of a physician. This device is restricted to use by a physician who has participated in specific implantation training for the ATS 3f® Aortic Bioprosthesis, Model 1000.

ATS Medical and ATS 3f are registered trademarks of ATS Medical, Inc. All rights reserved. ©2009 ATS Medical, Inc.